Hire an Advanced Robo-Advisor to Trade ZBH on Your Behalf.
- Street Sentiment
- Personalized Strategy
- Free Trading Simulator
Course of Action
Sentiment (10 days)
- Strong Buy
- Strong Sell
DAILY PRICE CHANGE VS SENTIMENT
What is Robo investing?
Smart Auto-Trading is an advanced robo-advisor designed to provides investors with a a state of the art automated trading tool to trade the S&P 500. Its robo is designed to screens, monitors and auto-trades elite stocks like ZIMMER BIOMET HOLDINGS (ZBH) using artificial intelligence, social media and market data to augments your potential as an investor.
What is it good at?
If you are interested in systematic, active investing, Smart Auto-Trading can be a great alternative to passive investing funds. Smart Auto-Trading uses artificial intelligence concepts to screen, monitor and auto-trade stocks. Used in a tax-deferred account such as an IRA, SIMPLE IRA, Rollover IRA, Keogh, 529 College Plan or UGMA it auto-trades systematically using your carefully defined strategy. Using Smart Auto-Trading is like having a professional trader working for you. You turn it on and it just works.
Smart Auto-Trading actively trades the S&P 500 day-in and day-out in your account while you attend more important life events. Because of the systematic nature of Smart Auto-Trading, your account has the potential to grow at a higher rate than if you were to use a passive investment vehicle such as an index fund or a mutual fund. Systematic active trading using artificial intelligence holds the potential to grow the account faster.
Using Smart Auto-Trading is Easy
To connect Smart Auto-Trading to your account you will need to open an account with Ally Invest, one of the most trusted broker/dealer in the United States. Ally Invest is the brokerage firm Stock Circles uses to auto-trade because Ally Invest offers a very competitive price per trade.
To open an account, please go to Ally Invest's account opening page is available at: https://invest.ally.com/ola/
Once the account is open, you are ready to transfer your money into the newly opened account. To do so, you will need to send a copy of your 401K or other account statement to Ally Invest as well as transfer instructions to firstname.lastname@example.org. Once they receive your instructions, a Customer Support specialist will help you complete the transfer.
After a few business days, the account will be funded and you will be ready to auto-trade using Smart Auto-Trading.
While this is in progress, you might want to test your strategy in simulation mode free of charge at stockcircles.com. Doing so will help you get comfortable with the product's benefits.
There are clear benefits associated with using a robo-advisor such as Smart Auto-Trading to help you reach your financial goals. Smart Auto-Trading simplifies stock investing down to a few steps. It auto-trades for you, using your personalized strategy, while you attend more important life events.
Using Smart Auto-Trading is like having thousands of traders working for you to help you reach your financial goals.
Smart Auto-Trading actively trades which is different from passive investing. The robo is on the lookout working to maximize your potential every business day of the year. It trades on the news taking advantage of price changes and trends by listening into trader's communications and by validating this information with market data.
Smart Auto-Trading is one of the first robo-advisor to take advantage of Government grade listening technology, artificial intelligence, social media and market data natively.
Try Smart Auto-Trading today!
You can test Smart Auto-Trading in simulation mode, risk free, Stock Circles today.
Disclaimer: Past performance may not be indicative of future results. Therefore, you should assume that the future performance of any specific investment, investment strategy (including robo-strategies), or product made in reference directly or indirectly on this website, will be profitable or equal to corresponding indicated performance levels. Robot-Advisors like other investment methods rely on favorable market conditions to provide positive outcomes.
ZIMMER BIOMET HOLDINGS (ZBH) News
Cramer Rosenthal Mcglynn LLC Sells 75,213 Shares of Zimmer Biomet Holdings, Inc. (ZBH)
Cramer Rosenthal Mcglynn LLC lessened its holdings in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 23.0% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 252,416 shares of the medical equipment provider’s stock after selling 75,213 shares during the quarter. Cramer Rosenthal Mcglynn LLC owned approximately 0.12% of Zimmer Biomet Holdings worth $32,410,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also modified their holdings of the company. Bronfman E.L. Rothschild L.P. lifted its stake in Zimmer Biomet Holdings by 25.3% in the second quarter. Bronfman E.L. Rothschild L.P. now owns 827 shares of the medical equipment provider’s stock valued at $106,000 after acquiring an additional 167 shares during the last quarter. Parkside Financial Bank & Trust grew its position in Zimmer Biomet Holdings by 3.9% in the second quarter. Parkside Financial Bank & Trust now owns 872 shares of the medical equipment provider’s stock worth $112,000 after acquiring an additional 33 shares in the last quarter. Parallel Advisors LLC increased its stake in shares of Zimmer Biomet Holdings by 20.8% during the 1st quarter. Parallel Advisors LLC now owns 1,157 shares of the medical equipment provider’s stock worth $138,000 after purchasing an additional 199 shares during the last quarter. IHT Wealth Management LLC increased its stake in shares of Zimmer Biomet Holdings by 28.4% during the 1st quarter. IHT Wealth Management LLC now owns 1,158 shares of the medical equipment provider’s stock worth $139,000 after purchasing an additional 256 shares during the last quarter. Finally, Sandy Spring Bank increased its stake in shares of Zimmer Biomet Holdings by 1.7% during the 1st quarter. Sandy Spring Bank now owns 1,222 shares of the medical equipment provider’s stock worth $149,000 after purchasing an additional 20 shares during the last quarter. 85.36% of the stock is currently owned by hedge funds and other institutional investors.
In related news, VP Tony W. Collins sold 16,986 shares of the company’s stock in a transaction dated Monday, July 31st. The shares were sold at an average price of $121.74, for a total value of $2,067,875.64. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 1.07% of the company’s stock.
Several equities research analysts recently issued reports on the stock. Morgan Stanley lifted their price objective on shares of Zimmer Biomet Holdings from $137.00 to $150.00 and gave the company an “overweight” rating in a research note on Monday, July 17th. Stifel Nicolaus reissued a “hold” rating and set a $125.00 target price on shares of Zimmer Biomet Holdings in a research report on Friday, July 14th. Piper Jaffray Companies reissued a “buy” rating and set a $141.00 target price on shares of Zimmer Biomet Holdings in a research report on Friday, July 14th. Bank of America Corporation restated a “buy” rating and set a $158.00 target price on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. Finally, Wells Fargo & Company restated a “market weight” rating on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. Three equities research analysts have rated the stock with a sell rating, eight have issued a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $136.55.
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) traded up 0.53% during midday trading on Wednesday, hitting $116.77. 593,495 shares of the company traded hands. The stock’s 50-day moving average price is $114.58 and its 200 day moving average price is $120.50. Zimmer Biomet Holdings, Inc. has a 12-month low of $95.63 and a 12-month high of $133.49. The company has a market capitalization of $23.61 billion, a price-to-earnings ratio of 33.26 and a beta of 1.19.
Zimmer Biomet Holdings (NYSE:ZBH) last issued its quarterly earnings data on Thursday, July 27th. The medical equipment provider reported $2.08 EPS for the quarter, missing analysts’ consensus estimates of $2.10 by ($0.02). The firm had revenue of $1.95 billion during the quarter, compared to analyst estimates of $1.95 billion. Zimmer Biomet Holdings had a net margin of 9.12% and a return on equity of 16.70%. The business’s quarterly revenue was up 1.1% compared to the same quarter last year. During the same period in the prior year, the company earned $2.02 earnings per share. On average, equities analysts forecast that Zimmer Biomet Holdings, Inc. will post $8.24 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, September 22nd will be given a $0.24 dividend. The ex-dividend date of this dividend is Thursday, September 21st. This represents a $0.96 dividend on an annualized basis and a dividend yield of 0.83%. Zimmer Biomet Holdings’s payout ratio is presently 27.59%.Get Started today! - Risk Free